WESA: PA Senate candidate pledges to debate following stroke
UC expert discusses stroke recovery
Democratic Pennsylvania Senate candidate John Fetterman suffered a stroke in May, but he has pledged that he will debate his Republican opponent Mehmet Oz when his recovery allows him to do so.
Fetterman's campaign has said that while the candidate's ability to understand and produce speech has been affected, his underlying cognition is unaffected.
Pittsburgh NPR affiliate WESA featured the University of Cincinnati's Pooja Khatri, MD, as a stroke expert. While she did not specifically address Fetterman's recovery, she said it is possible for patients to have difficulty with speech while their underlying cognition has not been affected.
“I'll have people tell me, ‘My loved one was confused because they have aphasia,’ and really, they're actually not confused at all,” said Khatri, professor of neurology and director of the vascular neurology division in the UC College of Medicine’s Department of Neurology and Rehabilitation Sciences; co-director of the UC Gardner Neuroscience Institute Stroke Center of Excellence and the NIH StrokeNet National Coordinating Center housed at UC; as well as a UC Health physician. “They're just having trouble getting the words out that they want to say or understanding what you're saying.”
Khatri added that one of the clearest signs of how well a stroke victim will recover in the long term is how they do in the days immediately following the stroke.
Featured photo at top of MRI brain scan. Photo/Ravenna Rutledge/University of Cincinnati.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.